Dr. Rabinder Prinjha FMedSci
Chief R&D Officer
Curve Therapeutics
Elected Fellow 2017
Immunology, Oncology, Epigenetics, Neurology. Drug discovery and early development.
Rabinder Prinjha is VP Head of Epinova Epigenetics. An outstanding scientist who is a world leading figure in the emerging field of epigenetics drug discovery, and is also a very active leader at the industry-academic interface helping to advance medical science. His high impact translational science and the molecules his group has discovered have made him the partner of choice for two leading academic laboratories. His work is widely recognised as a key contribution to the field and in addition to this he is very active in supporting science and is leading the EU Innovative Medicines Initiative Immunology Strategic Governance Group.